Newsletter
Mayo Clinic Talks

Mayo Clinic Talks

Stay on top of your practice with podcasts from colleagues at Mayo Clinic.

Latest From Series

Genes & Your Health Edition – Why Does It Matter? Genes, Hormones, and Women’s Health

To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health Guests: Stephanie S. Faubion, M.D., M.B.A. (@StephFaubionMD); Kejal Kantarci, M.D. (@KejalKantarciMD); Juliana (Jewel) M. Kling, M.D., M.P.H. (@DrJewelKling) Host: Denise M. Dupras, M.D., Ph.D. Is hormone therapy good or bad for women? What are the myths surrounding it? Is the varying experience of menopause genetic? Join the sixth episode of Mayo Clinic Center for Individualized Medicine’s Genes & Your Health Edition to dive into women’s health and hormones and what you need to know for your practice.   Additional resources: • USPSTF Recommendations Statement for Breast Cancer: Medication Use to Reduce Risk https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction  • Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine  Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
October 14, 2021

Using Artificial Intelligence to Combat COVID-19

Guest: Thomas Caulfield, Ph.D. Host: Amit K Ghosh, M.D., MBA (@AmitGhosh006) In this podcast, Dr. Thomas Caulfield from Mayo Clinic Florida describes a novel approach for SARS-CoV2 multi-drug targeting using artificial intelligence. Dr. Caulfield is leading a national team of investigators from Harvard, University of California, In Vivo Biosystems and Mayo Clinic to perform large-scale in silico and in vivo experiments on de novo drugs to better understand COVID-19 and halt its progression.  University of California hosts a live virus BSL3 facility for rapidly screening novel compounds that Dr. Caulfield's lab designs in silico and refines with feedback using machine learning techniques and data layering. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
October 12, 2021

Genes & Your Health Edition – How Does Your Microbiome Impact Your Health?

To claim credit for this series, visit: Mayo Clinic Talks Podcast: Genes & Your Health Guest: Purna C. Kashyap, M.B.B.S. (@KashyapPurna); Marina R. Walther-Antonio, Ph.D. Host: Denise M. Dupras, M.D., Ph.D. What is the microbiome? How does the microbiome interact with our body? How much of us is nurture, how much is nature? The whole concept of microbiome may be a new idea but have no fear this fifth episode of the Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine is here to help answer those questions and more! Additional resources: Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine  Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
October 7, 2021

Mayo Clinic Q&A: Breaking Down COVID-19 Vaccine Booster Approvals

This episode is shared from Mayo Clinic Q&A and was recorded in September 29, 2021 Guest:  Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) The path to approvals for a booster dose of the Pfizer COVID-19 vaccine has seemed complicated.  "This is a confusing set of recommendations," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "So let's look at the four groups approved for only the Pfizer booster, thus far. If you got a primary series of the Pfizer vaccine, you're 65 and older, and it's been six months or more, you are eligible for a booster. If you're 50–64 and you have medical conditions that place you at high risk, you are eligible for the booster. If you're 18–49, you may be able to get a booster based on a medical condition and if you talk with your health care provider to weigh risks and benefits. And, finally, for people 18–64 years old, who are health care providers in congregate living situations or who have occupations that place them at high risk for transmission, such as school teachers, they also may be eligible. That should happen very soon." In this Mayo Clinic Q&A podcast, Dr. Poland talks more about the approval process for COVID-19 vaccine boosters, including for the Moderna and Johnson & Johnson COVID-19 vaccines. He also discusses the possibility that emergency use approval for children, down to age 5, could come before the end of October. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
October 6, 2021

Breast Imaging for Patients with Dense Breast Tissue

Guest: Christina A. Dilaveri, M.D. (@CDilaveri) Host: Darryl S. Chutka, M.D. (@ChutkaMD)   Breast cancer is very treatable when detected early. Therefore, early detection becomes very important as it significantly reduces a patient’s risk of developing metastases and death. Breast imaging plays an extremely important role in the detection of early breast cancer, and we now have several modalities of breast imaging available, each with its advantages and disadvantages. Our guest for this podcast is Christina Dilaveri, M.D. a breast disease specialist, from Mayo Clinic’s Rochester Campus. We’ll discuss mammography, ultrasound, MRI, and molecular breast imaging, when they’re indicated, and the advantages of each. You’ll hear which patients should have more than a mammogram and how often it should be performed. Specific topics discussed: The various types of mammography available Indications for breast ultrasound Benefits of breast MRI When breast MRI should be performed Benefits of molecular breast imaging When molecular breast imaging should be performed Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
October 5, 2021

Genes & Your Health Edition – Genomics and Cancer: Primary Care Impact and Research Advances

To claim credit for this series, visit: Mayo Clinic Talks Podcast: Genes & Your Health   Guest: Niloy Jewel J. Samadder, M.D. (@J_Samadder)   Host: Denise M. Dupras, M.D., Ph.D.   Can we find the cause of a patient’s cancer? Is it possible to provide targeted treatment to prevent future cancers by understanding what genetic predispositions a patient or their family members have? In a recently published study, nearly one in six to one in eight cancer patients, depending on which type of cancer they had, carried a genetic predisposition to the development of their cancer. How can we translate these findings into our practice for the benefit of our patients and their families? Tune in to episode four of our Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine. Additional resources: Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. 2021;7(2):230–237. doi: 10.1001/jamaoncol.2020.6252 Uson, PLS. Riegert-Johnson, D. Boardman, L. Kisiel, J. et al. Germline cancer susceptibility gene testing in unselected patients with colorectal adenocarcinoma: a multicenter prospective study. Clin Gastroenterol Hepatol. 2021 April 20; doi: 10.1016/j.cgh.2021.04.013 Mayo Clinic’s Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine  Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
September 30, 2021

Mayo Clinic Talks

Stay on top of your practice with podcasts from colleagues at Mayo Clinic.

Curated. Portable. Trusted.

Opinions expressed in the podcast do not necessarily reflect those of Mayo Clinic.
View All Episodes

Host

Darryl Chutka, M.D.

Darryl Chutka, M.D.

Internist | Geriatrician | Educator | Host

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
COVID, AI, and the Future of Medicine with Eric Topol Exploring lingering questions about COVID-19 with Eric Topol, the Founder and Director of the Scripps Research Translational Institute.